BC Platforms raised €9.1M in a Series B round in May 2017. The company is based in Basel, Switzerland. Investors in the round: Debiopharm Group, Tesi. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
